ESCRS - PO236 - Seven-Year Outcomes With Premium Intraocular Lenses

Seven-Year Outcomes With Premium Intraocular Lenses

Published 2022 - 40th Congress of the ESCRS

Reference: PO236 | Type: ESCRS 2022 - Posters | DOI: 10.82333/bpb3-ay87

Authors: Demetrios Pirounides* 1 , Georgios Balanikas 1 , Ioannis Chalkias 1 , Efthymios Chalkias 1 , Panagiotis Ageladarakis 1 , Aikaterini Giannoukaki 1

1Ahepa,THESSALONIKI,Greece

Purpose

To report the preoperative, intraoperative, and postoperative outcomes of phacoemulsification with premium intraocular lens (IOL) implantation.

Setting

Department of Ophthalmology, AHEPA University hospital.

 

Methods

Retrospective study of patients with cataract undergoing phacoemulsification by a single surgeon, at the AHEPA University Hospital, Thessaloniki, between March 2015  and March 2022. They were implanted with enhanced monofocal depth of focus (TECNIS Eyhance IOL; model ICB00/DIB; 7 patients), multifocal (Alcon Laboratories, AcrySof IQ PanOptix,  model TFNT00; 4 patients), or toric (Alcon Laboratories, AcrySof IQ model Toric SN6ATT) IOLs. Parameters including patient characteristics (i.e.  age, gender, comorbidities), type of surgery and perioperative manoeuvers employed, difficulties and preoperative visual acuity were analyzed. The secondary outcomes were quality of vision and spectacle independence.

Results

19 out of 2173 eyes were included. Primary outcomes were the post-op monocular uncorrected distance (UDVA), intermediate (UIVA), and near (UNVA) visual acuity at 1 month. The secondary outcomes were quality of vision and spectacle independence. UNVA were statistically better for trifocal IOLs than for the EDOF IOL and the toric IOL. 85% of EDOF IOLs showed a postoperative spherical equivalent within ±0.50 D diopters (D) while at the same group, a total of 100%  and 85% of eyes showed UDVA and UIVA of 6/7.5 or better, respectively. There was no significant difference in UDVA between groups; UIVA was better than 6/9 in 100%, 50%, and 85% of patients with the multifocal, toric, and enhanced monofocal IOLs, respectively.

 

Conclusions

All three IOLs provided great UDVA contributing to patient daily functioning. Multifocal and enhanced monofocal IOLs provide a greater depth of focus and little impact of visual symptoms. Compared to the two other groups, multifocal IOLs provide better near vision. Toric intraocular lenses is an effective option when they are utilized for patients with astigmatism. Vigilant preoperative assessment is the key for accurate results, leading to right patient selection for premium IOLs.